Literature DB >> 9444773

Iron chelators for clinical use.

G S Tilbrook1, R C Hider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9444773

Source DB:  PubMed          Journal:  Met Ions Biol Syst        ISSN： 0161-5149


× No keyword cloud information.
  7 in total

1.  Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.

Authors:  Yongmin Ma; Herbert de Groot; Zudong Liu; Robert C Hider; Frank Petrat
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 2.  Acquisition, transport, and storage of iron by pathogenic fungi.

Authors:  D H Howard
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

3.  Interactions of the pyridine-2-carboxaldehyde isonicotinoyl hydrazone class of chelators with iron and DNA: implications for toxicity in the treatment of iron overload disease.

Authors:  Timothy B Chaston; Des R Richardson
Journal:  J Biol Inorg Chem       Date:  2003-02-05       Impact factor: 3.358

4.  New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators - Reaction of amines with a novel electrophilic 3,2-HOPO precursor.

Authors:  Timothy N Lambert; Sumathi Chittamuru; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2002-10-07       Impact factor: 2.415

Review 5.  Chelation in metal intoxication.

Authors:  Swaran J S Flora; Vidhu Pachauri
Journal:  Int J Environ Res Public Health       Date:  2010-06-28       Impact factor: 3.390

Review 6.  Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications.

Authors:  Ole Andersen; Jan Aaseth
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

7.  Synthesis of polymers containing 3-hydroxypyridin-4-one bidentate ligands for treatment of iron overload.

Authors:  Lotfollah Saghaie; Dy Liu; Robert C Hider
Journal:  Res Pharm Sci       Date:  2015 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.